Paid Clinical Trials in Glen Burnie, MD
As of August 2026, 51 paid clinical trials are recruiting in Glen Burnie, Maryland. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Glen Burnie offers studies at sites including UM Baltimore Washington Medical Center/Tate Cancer Center for conditions such as Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Colitis, Ulcerative, Crohn's Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Glen Burnie
Trials by drug in Glen Burnie
Filter results
47 clinical trials
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
E-Mindfulness Approaches for Living After Breast Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
TERPS Trial for de Novo Oligometastic Prostate Cancer
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial
Top Research Study Locations in Glen Burnie
Researchers run research studies in Glen Burnie, MD at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UM Baltimore Washington Medical Center/Tate Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Melanoma | 14 |
| Baltimore Washington Medical Center | Brain Tumor, Glioblastoma, Glioma | 6 |
| United Theranostics | Breast Cancer, Breast Neoplasms, Cervical Adenocarcinoma | 5 |
| University of Maryland Baltimore Washington Medical Center | Healthy Volunteers (HV), Unhealthy Volunteers, Breast Cancer (Locally Advanced or Metastatic) | 4 |
| Woodholme Gastroenterology Associates | Crohn's Disease, Colitis, Ulcerative, Crohn Disease | 4 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Baltimore Washington Medical Center- Tate Cancer Center | Cervical Cancer, Gynaecologic Cancer, Non-Small Cell Lung Cancer | 2 |
| Woodholme Gastroenterology | Chronic Idiopathic Constipation (CIC), Crohn's Disease, Ulcerative Colitis | 2 |
| Advanced Molecular Imaging and Therapy | Breast Cancer, Cervical Cancer, Colon Cancer | 1 |
| Clearway Pain Solutions | Lumbar Spinal Stenosis | 1 |
| Johns Hopkins Community Physicians, Glen Burnie | Adolescent Alcohol Use | 1 |
| National Spine and Pain Centers | Lumbar Spinal Stenosis | 1 |
| Research Facility | Carcinoid, Carcinoid Tumor, GEP-NET | 1 |
| Sleep Disorders Centers of the Mid-Atlantic | OSA | 1 |
| SurgCenter of Glen Burnie | Lumbar Spinal Stenosis | 1 |
| TG Therapeutics Investigational Trial Site | Multiple Sclerosis, Relapsing Multiple Sclerosis | 1 |
| Tate Cancer Center at UM Baltimore Washington | Breast Cancer | 1 |
| United Theranostics - Chesapeake | Breast Cancer, Cervical Cancer, Colon Cancer | 1 |
| University of Maryland - Baltimore Washington Medical Center | Respiratory Distress Syndrome, Acute | 1 |
| Woodholme Gastroenterology Associates - Glen Burnie | Overweight or Obesity and Elevated Liver Fat | 1 |
| Woodholme Gastroenterology Associates PA | Colitis, Ulcerative | 1 |
Active & Upcoming Studies in Glen Burnie (2026)
Recruiting trials in Glen Burnie grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (32 active studies)
- Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer · University of Maryland, Baltimore
- Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer · University of Maryland, Baltimore
Diabetes & metabolic (3 active studies)
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Neurology & pain (1 active study)
Pediatric (1 active study)
Common conditions studied in Glen Burnie
- Breast Cancer (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Colitis, Ulcerative (3 active studies)
- Crohn's Disease (3 active studies)
- Glioblastoma (3 active studies)
- Ulcerative Colitis (3 active studies)
Leading research sponsors in Glen Burnie
- University of Maryland, Baltimore
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
- Takeda
Frequently asked questions
How many paid clinical trials are currently recruiting in Glen Burnie?
There are approximately 51 recruiting clinical trials in Glen Burnie, Maryland listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Glen Burnie pay participants?
Most recruiting trials in Glen Burnie compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Glen Burnie?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Glen Burnie?
The most common conditions under active study in Glen Burnie include Breast Cancer (6), Anatomic Stage II Breast Cancer AJCC v8 (3), Colitis, Ulcerative (3), Crohn's Disease (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Glen Burnie?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Glen Burnie on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Glen Burnie?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Glen Burnie?
Recruiting research sites in Glen Burnie include UM Baltimore Washington Medical Center/Tate Cancer Center, Baltimore Washington Medical Center, United Theranostics, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Glen Burnie right now?
The largest active categories in Glen Burnie are Cancer & tumors (32), Diabetes & metabolic (3), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.